Athira Pharma, Inc.(ATHA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATHA Athira Pharma, Inc.

休市中 05-17 16:00:00 EDT

2.52

-0.19

-7.01%

盘后2.52

+0.000.00%

18:18 EDT

最高2.70	最低2.46	成交量18.01万
今开2.70	昨收2.71	日振幅8.86%
总市值9,658万	流通市值6,784万	总股本3,833万
成交额45.69万	换手率0.67%	流通股本2,692万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATHA","market":"US","secType":"STK","nameCN":"Athira Pharma, Inc.","latestPrice":2.52,"timestamp":1715976000000,"preClose":2.71,"halted":0,"volume":180102,"hourTrading":{"tag":"盘后","latestPrice":2.52,"preClose":2.52,"latestTime":"18:18 EDT","volume":78,"amount":196.61,"timestamp":1715984329798},"delay":0,"floatShares":26920517,"shares":38326652,"eps":-3.094987,"marketStatus":"休市中","marketStatusCode":7,"change":-0.19,"latestTime":"05-17 16:00:00 EDT","open":2.7,"high":2.7,"low":2.46,"amount":456858.0436056,"amplitude":0.088561,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.094987,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1600401600000,"adjPreClose":2.71,"postHourTrading":{"tag":"盘后","latestPrice":2.52,"preClose":2.52,"latestTime":"18:18 EDT","volume":78,"amount":196.61,"timestamp":1715984329798},"volumeRatio":1.001095021927753},"requestUrl":"/m/hq/s/ATHA/","defaultTab":"news","newsList":[{"id":"2435969835","title":"阿蒂拉制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435969835","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435969835?lang=zh_cn&edition=full","pubTime":"2024-05-16 05:18","pubTimestamp":1715807916,"startTime":"0","endTime":"0","summary":"   * Athira Pharma Inc   报告，截至3月底的季度调整后每股亏损69美分，高于去年同期的每股-73美分。五位分析师对该季度的平均预期是每股亏损 79 美分。* Athira Pharma Inc 公布的季度每股收益为亏损 69 美分。* 该公司当季亏损 2634 万美元。* Athira Pharma Inc 本季度股价下跌了 19.7%，今年迄今为止下跌了 9.5%。5月15日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 16.8%。华尔街对 Athira Pharma Inc 的 12 个月目标价中位数为 4.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435372256","title":"Athira Pharma, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435372256","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435372256?lang=zh_cn&edition=full","pubTime":"2024-05-13 23:26","pubTimestamp":1715613971,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日23时26分，Athira Pharma, Inc.股票出现异动，股价快速上涨5.19%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051323261187e878f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051323261187e878f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434010809","title":"Athira Pharma, Inc.盘中异动 快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434010809","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434010809?lang=zh_cn&edition=full","pubTime":"2024-05-10 00:28","pubTimestamp":1715272082,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日00时28分，Athira Pharma, Inc.股票出现异动，股价大幅上涨5.14%。截至发稿，该股报2.25美元/股，成交量14.7441万股，换手率0.38%，振幅5.14%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100028027926cd09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100028027926cd09&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433578523","title":"Athira Pharma, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433578523","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433578523?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:19","pubTimestamp":1715091588,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时19分，Athira Pharma, Inc.股票出现波动，股价快速拉升5.08%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722194879264cbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722194879264cbd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431869837","title":"Athira Pharma, Inc.盘中异动 早盘急速上涨5.21%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431869837","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431869837?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:33","pubTimestamp":1714397583,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时33分，Athira Pharma, Inc.股票出现异动，股价大幅拉升5.21%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Immunitybio, Inc.、Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为434.83%、22.85%、10.50%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Immunitybio, Inc.，振幅分别为28.57%、17.43%、11.05%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921330487e84bc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921330487e84bc4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430231112","title":"Athira Pharma, Inc.盘中异动 股价大跌5.47%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231112","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430231112?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:35","pubTimestamp":1714062955,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日00时35分，Athira Pharma, Inc.股票出现异动，股价大幅跳水5.47%。截至发稿，该股报1.90美元/股，成交量9.5069万股，换手率0.25%，振幅4.48%。Athira Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600355679238245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600355679238245&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427694004","title":"Athira Pharma, Inc.盘中异动 股价大跌5.33%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427694004","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427694004?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:11","pubTimestamp":1713190287,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时11分，Athira Pharma, Inc.股票出现波动，股价急速跳水5.33%。截至发稿，该股报2.31美元/股，成交量6.3147万股，换手率0.16%，振幅6.76%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041522112887e80763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041522112887e80763&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.athira.com","stockEarnings":[{"period":"1week","weight":0.1887},{"period":"1month","weight":0.1943},{"period":"3month","weight":-0.2961},{"period":"6month","weight":0.4911},{"period":"1year","weight":-0.1127},{"period":"ytd","weight":0.037}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Athira Pharma, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology，Inc.，并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司，致力于开发小型药物分子来恢复神经元健康并阻止神经变性。凭借公司的候选产品，它旨在通过其新颖的作用机制提供快速的认知改善，并改变神经系统疾病的病程。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.002015},{"month":2,"riseRate":0.5,"avgChangeRate":-0.024771},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042184},{"month":4,"riseRate":0.5,"avgChangeRate":-0.083309},{"month":5,"riseRate":0.5,"avgChangeRate":0.04191},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.361858},{"month":7,"riseRate":0.333333,"avgChangeRate":0.023097},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.054353},{"month":9,"riseRate":0,"avgChangeRate":-0.10991},{"month":10,"riseRate":0.5,"avgChangeRate":0.064619},{"month":11,"riseRate":0.5,"avgChangeRate":0.068191},{"month":12,"riseRate":0.75,"avgChangeRate":0.262228}],"exchange":"NASDAQ","name":"Athira Pharma, Inc.","nameEN":"Athira Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Athira Pharma, Inc.(ATHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Athira Pharma, Inc.(ATHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Athira Pharma, Inc.,ATHA,Athira Pharma, Inc.股票,Athira Pharma, Inc.股票老虎,Athira Pharma, Inc.股票老虎国际,Athira Pharma, Inc.行情,Athira Pharma, Inc.股票行情,Athira Pharma, Inc.股价,Athira Pharma, Inc.股市,Athira Pharma, Inc.股票价格,Athira Pharma, Inc.股票交易,Athira Pharma, Inc.股票购买,Athira Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Athira Pharma, Inc.(ATHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Athira Pharma, Inc.(ATHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况